“Goldman Sachs: 2 Stocks That Could Climb Over 90%”
October 19, 2020
“Athira Pharma (ATHA)…
Judging by the consensus breakdown, opinions are anything but mixed. With 4 Buys and no Holds or Sells assigned in the last three months, the word on the Street is that ATHA is a Strong Buy. At $42.50, the average price target implies 132% upside potential…
Denali Therapeutics (DNLI)…
Looking at the consensus breakdown, 6 Buys and 2 Holds have been issued in the last three months. Therefore, DNLI gets a Strong Buy consensus rating. Based on the $51.17 average price target, shares could surge 16% in the next year…”
https://finance.yahoo.com/news/goldman-sachs-2-stocks-could-150019682.html